Mavragani et al. (27) tested 75 APS patients (40 primary APS and 35 APS secondary to SLE), 75 SLE patients and 75 healthy controls for anti-Tg and anti-TPO antibodies. This evidence concerns the gene TPO and autoimmune polyendocrinopathy.